YU51601A - Himerni gen koji kodira antigene determinante četiri proteina l.infantum - Google Patents

Himerni gen koji kodira antigene determinante četiri proteina l.infantum

Info

Publication number
YU51601A
YU51601A YU51601A YU51601A YU51601A YU 51601 A YU51601 A YU 51601A YU 51601 A YU51601 A YU 51601A YU 51601 A YU51601 A YU 51601A YU 51601 A YU51601 A YU 51601A
Authority
YU
Yugoslavia
Prior art keywords
proteins
gene encoding
chimeric gene
infantum
antigenic determinants
Prior art date
Application number
YU51601A
Other languages
English (en)
Inventor
Alonso Carlos Bedate
Original Assignee
C.B.F. Leti S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.B.F. Leti S.A. filed Critical C.B.F. Leti S.A.
Publication of YU51601A publication Critical patent/YU51601A/sh
Publication of RS50013B publication Critical patent/RS50013B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Dati pronalazak se odnosi na farmaceutski preparat za prevenciju i lečenje leišmanioze, kod ljudi ili životinja. Farmaceutski preparat sadrži protein himera Q, koji je proizvod himernog gena koji kodira antigene determinante četiri proteina vrste Leishmania infantum.[The present invention relates to a pharmaceutical composition for the prevention and treatment, human or animal, of leishmaniasis. The pharmaceutical composition contains the protein chimera Q, which is the product of a chimeric gene encoding the antigenic determinants of four proteins of Leishmania infantum.
YUP-516/01A 1998-12-23 1999-12-23 Himerni gen koji kodira antigene determinante četiri proteina l.infantum RS50013B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (en) 1998-12-23 1998-12-23 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans

Publications (2)

Publication Number Publication Date
YU51601A true YU51601A (sh) 2005-07-19
RS50013B RS50013B (sr) 2008-09-29

Family

ID=27671952

Country Status (5)

Country Link
JP (1) JP4883839B2 (sh)
BR (1) BRPI9917863B8 (sh)
CA (1) CA2256124C (sh)
RS (1) RS50013B (sh)
ZA (1) ZA200105994B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG190222A1 (en) * 2010-11-10 2013-06-28 Leti Sl Lab New adjuvant

Also Published As

Publication number Publication date
BRPI9917863C1 (pt) 2021-05-25
CA2256124A1 (en) 2000-06-23
JP2002533474A (ja) 2002-10-08
RS50013B (sr) 2008-09-29
ZA200105994B (en) 2002-07-22
JP4883839B2 (ja) 2012-02-22
BRPI9917863B1 (pt) 2016-08-02
BRPI9917863B8 (pt) 2022-08-30
CA2256124C (en) 2015-06-16
BRPI9917863A2 (sh) 2010-12-21

Similar Documents

Publication Publication Date Title
BE2016C049I2 (sh)
ATE348113T1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
PT2009025E (pt) Método de inibição da actividade dos osteoclastos
HK1043937A1 (zh) Bpi蛋白質產品的人類醫療用途
IL92937A0 (en) Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
YU51601A (sh) Himerni gen koji kodira antigene determinante četiri proteina l.infantum
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001095946A3 (en) Combination product for carrying out a cytotoxic treatment in a mammal
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001016319A3 (en) Compositions and methods for the treatment of immune related diseases
ATE213637T1 (de) Bismut enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
AU7043301A (en) A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence
ATE480560T1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
MX9800686A (es) Nueva proteina hmw humana mp52s.
EP1529842A3 (en) Compositions and methods for the treatment of immune related diseases